• +852 2528 3061
  • +852 2865 6283
  • [email protected]
EN|中
  • About HKAPI
  • Code of Practice
  • Position Papers
  • What’s New
    • Upcoming Training
    • Events
    • Newsletters
  • Member’s Area
  • Resources
  • About HKAPI
  • Code of Practice
  • Position Papers
  • What’s New
    • Upcoming Training
    • Events
    • Newsletters
  • Member’s Area
  • Resources
05 Apr 23

Appointment of New Board Members

  • vickyhkapi
  • No Comments
HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).
Read More
22 Mar 23

Successful AGM of the Hong Kong Association of the Pharmaceutical Industry

  • vickyhkapi
  • No Comments
We are delighted to announce that the Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry was held successfully on 22nd March 2023.
Read More
16 Feb 23

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

  • vickyhkapi
  • No Comments
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
Read More
13 Feb 23

Briefing session for Regulatory Intelligence Survey

  • vickyhkapi
  • No Comments
The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
Read More
11 Jan 23

Code of Practice Train-the-Trainer Workshop 2023

  • vickyhkapi
  • No Comments
More than 260 members attended the Code of Practice Train-the-Trainer Workshop on 11 January 2023 to understand the key changes of the Code and its implications for HKAPI members.
Read More
09 Jan 23

Appointment of New Board Member

  • vickyhkapi
  • No Comments
We are pleased to announce that Mr. Derek Chang has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 9th January 2023.
Read More

DH met with HKAPI on maintaining steady supply of paracetamol

  • January 9, 2023
  • vickyhkapi
  • No Comments
The DH met virtually with pharmaceutical associations to discuss a series of measures to maintain the steady supply of medicines.
Read More
11 Nov 22

Asia Summit on Global Health 2022

  • vickyhkapi
  • No Comments
Asia Summit on Global Health 2022 It is a great privilege for The Hong Kong Association of the Pharmaceutical Industry to join the Asia Summit on Global Health 2022 organized […]
Read More
07 Oct 22

Extraordinary General Meeting 2022

  • vickyhkapi
  • No Comments
An online EGM was called by the HKAPI Board to pass a resolution to adopt the new Code of Practice. It was unanimously adopted by members with immediate effect.
Read More
06 Sep 22

Appointment of New Board Member

  • vickyhkapi
  • No Comments
HKAPI is pleased to announce that Mr. Howard Lin has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 6th September 2022.
Read More
1 … 3 4 5 … 7

Recent Posts

  • CEO Meeting – Enlistment of Innovative Medicine in Hong Kong
  • Innovation for a Sustainable Healthcare System: HKAPI Celebrates Its 58th Anniversary Dinner
  • Strengthening Ethical Standards: HKAPI Holds Code of Practice Train-the-Trainer Workshop
  • HKAPI AGM and Formation of the New Board
  • Regulatory Intelligence Sharing

Categories

  • Advocacy27
  • Association News123
  • Business1
  • Code of Practice15
  • Industry News35
  • Market Access20
  • Patient Empowerment8
  • Primary Healthcare4
  • Public Education6
  • Recreational9
  • Regulatory Affairs22
  • Strategy47
  • Workshop & Training68

Archives

  • October 2026 1
  • June 2026 1
  • April 2026 1
  • March 2026 2
  • January 2026 1
  • December 2025 1
  • September 2025 1
  • August 2025 2
  • July 2025 1
  • June 2025 2
  • April 2025 2
  • March 2025 2
  • February 2025 2
  • January 2025 1
  • November 2024 2
  • October 2024 1
  • August 2024 4
  • June 2024 1
  • May 2024 1
  • April 2024 2
  • March 2024 1
  • January 2024 2
  • December 2023 3
  • November 2023 3
  • October 2023 4
  • July 2023 2
  • June 2023 1
  • May 2023 3
  • April 2023 1
  • March 2023 4
  • February 2023 2
  • January 2023 3
  • November 2022 2
  • October 2022 1
  • September 2022 1
  • August 2022 1
  • July 2022 2
  • June 2022 2
  • April 2022 3
  • March 2022 3
  • February 2022 1
  • January 2022 3
  • December 2021 2
  • November 2021 1
  • October 2021 2
  • September 2021 1
  • May 2021 2
  • April 2021 1
  • March 2021 1
  • January 2021 1
  • December 2020 1
  • November 2020 1
  • October 2020 2
  • September 2020 1
  • April 2020 1
  • February 2020 2
  • December 2019 4
  • November 2019 1
  • October 2019 2
  • September 2019 1
  • August 2019 2
  • June 2019 4
  • May 2019 3
  • April 2019 3
  • March 2019 2
  • February 2019 2
  • December 2018 2
  • November 2018 4
  • October 2018 1
  • May 2018 1
  • April 2018 1
  • March 2018 2
  • February 2018 1
  • January 2018 1
  • December 2017 2
  • November 2017 3
  • October 2017 1
  • September 2017 2
  • August 2017 1
  • May 2017 1
  • March 2017 3
  • January 2017 2
  • December 2016 2

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use